Glycogen storage disease type II primary prevention: Difference between revisions
Irfan Dotani (talk | contribs) (Created page with "__NOTOC__ {{Glycogen storage disease type II}} {{CMG}}; {{AE}} {{PleaseHelp}} ==Overview== ==Primary Prevention== ==References== {{reflist|2}} Category:Endocrinology...") |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | |||
There are no established measures for the primary prevention of [disease name]. | |||
OR | |||
There are no available vaccines against [disease name]. | |||
OR | |||
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3]. | |||
OR | |||
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3]. | |||
==Primary Prevention== | ==Primary Prevention== | ||
*There are no established measures for the primary prevention of [disease name]. | |||
*There are no available vaccines against [disease name]. | |||
OR | |||
*Effective measures for the primary prevention of [disease name] include: | |||
**[Measure1] | |||
**[Measure2] | |||
**[Measure3] | |||
OR | |||
*[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include: | |||
**[Strategy 1] | |||
**[Strategy 2] | |||
**[Strategy 3] | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 16:26, 5 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II primary prevention On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II primary prevention |
Glycogen storage disease type II primary prevention in the news |
Blogs on Glycogen storage disease type II primary prevention |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Primary Prevention
- There are no established measures for the primary prevention of [disease name].
- There are no available vaccines against [disease name].
OR
- Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3]
OR
- [Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]